United States· US:58657-454_41b576a1-2a59-9f3c-e063-6394a90aec7d
Me NaPhos MB Hyo 1
A medicinal product containing methenamine; sodium phosphate, monobasic, monohydrate; methylene blue anhydrous; hyoscyamine sulfate anhydrous, registered in United States by Method Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; METHYLENE BLUE ANHYDROUS; HYOSCYAMINE SULFATE ANHYDROUS
- Manufacturer
- Method Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115865745401100 TABLET in 1 BOTTLE (58657-454-01)
- ndc1158657-454-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f708d0d8-489e-4b05-9e75-a82fed08c111 GET /v1/drugs/f708d0d8-489e-4b05-9e75-a82fed08c111?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "81.6; 40.8; 10.8; .12",
"substance": "METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; METHYLENE BLUE ANHYDROUS; HYOSCYAMINE SULFATE ANHYDROUS",
"productndc": "58657-454",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1; mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about methenamine; sodium phosphate, monobasic, monohydrate; methylene blue anhydrous; hyoscyamine sulfate anhydrous.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.